2024-09-21 |
YASVBOM0065500 |
MANKIND PHARMA LTD |
4223.0 kg |
250100
|
SODIUM CHLORIDE INHALATION SOLUTION |
2024-09-21 |
YASVBOM0065496 |
MANKIND PHARMA LTD |
7254.0 kg |
250100
|
SODIUM CHLORIDE INHALATION SOLUTION |
2024-09-21 |
YASVBOM0065497 |
MANKIND PHARMA LTD |
3157.0 kg |
250100
|
SODIUM CHLORIDE INHALATION SOLUTION |
2024-09-19 |
YASVBOM0065018 |
MANKIND PHARMA LTD |
6263.0 kg |
291229
|
NITROFURANTOIN CAPSULES USP |
2024-09-19 |
YASVBOM0065362 |
MANKIND PHARMA LTD |
7675.0 kg |
250100
|
SODIUM CHLORIDE INHALATION SOLUTION |
2024-09-09 |
YASVBOM0065234 |
MANKIND PHARMA LTD |
4426.0 kg |
291229
|
NITROFURANTOIN CAPSULES USP (MACROC |
2024-09-06 |
YASVBOM0065034 |
MANKIND PHARMA LIMITED |
829.0 kg |
281420
|
TOBRAMYCIN INHALATION SOLUTION |
2024-09-06 |
YASVBOM0065033 |
MANKIND PHARMA LIMITED |
5976.0 kg |
281420
|
TOBRAMYCIN INHALATION SOLUTION |
2024-09-06 |
YASVBOM0065060 |
MANKIND PHARMA LIMITED |
8264.0 kg |
291614
|
OMEGA-3-ACID ETHYL ESTERS CAPSULES |
2024-09-03 |
YASVBOM0064967 |
MANKIND PHARMA LIMITED |
7388.0 kg |
250100
|
SODIUM CHLORIDE INHALATION SOLUTION |
2024-09-03 |
YASVBOM0065117 |
MANKIND PHARMA LTD |
9750.0 kg |
291229
|
NITROFURANTOIN CAPSULES USP |
2024-08-24 |
YASVBOM0064765 |
MANKIND PHARMA LIMITED |
8370.0 kg |
848041
|
HALOPERIDOL DECANOATE INJECTION |
2024-08-24 |
YASVBOM0064766 |
MANKIND PHARMA LIMITED |
4807.0 kg |
281420
|
TOBRAMYCIN INHALATION SOLUTION |
2024-07-27 |
YASVBOM0064351 |
MANKIND PHARMA LIMITED |
17397.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PRODUCTS |
2024-07-27 |
YASVBOM0064352 |
MANKIND PHARMA LIMITED |
3715.0 kg |
300510
|
PHARMACEUTICAL |
2024-07-23 |
YASVBOM0064244 |
MANKIND PHARMA LTD |
9771.0 kg |
300510
|
GENERIC PHARMACEUTICAL |
2024-07-23 |
YASVBOM0064245 |
MANKIND PHARMA LTD |
9264.0 kg |
300510
|
GENERIC PHARMACEUTICAL |
2024-07-10 |
MFSRUS018759 |
MANKIND PHARMA LTD |
6000.0 kg |
392330
|
FORMOTEROL FUMARATE INHALATION SOLUTION, 20MCG/2ML 30X2ML ARFORMOTEROL TARTRATE INHALATIONSOLUTION 15 MCG/2 ML (0.015 MG/2 ML) 60X2ML STERILE UNIT-DOSE VIALS (15X4 UNIT DOSE VIALSPER POUCH) |
2024-07-10 |
MFSRUS018760 |
MANKIND PHARMA LTD |
19252.0 kg |
291229
|
ATORVASTATIN CALCIUM TABLETS 20 MG, 90 S CT FENOFIBRATE TABLETS USP 54 MG 90 S FENOFIBRATETABLETS USP 54 MG 500 S ATORVASTATIN CALCIUM TABLETS 10 MG, 1000 S CT LIDOCAINE HCL INJ., USP 2% (100 MG/5 ML) (20 MG/ML)- PRESERVATIV E FREE, 25X5ML PHENYLEPHRINE HYDROCHLORIDE INJ., USP, 50MG/5ML (10MG/ML), 10X5ML PHENYLEPH RINE HYDROCHLORIDE INJ., USP, 100MG/10ML (10MG/ML), 10ML ATORVASTATIN CALCIUM TABLETS 80 MG, 90 S CT ACETAZOLAMIDE TABLETS USP 125 MG 100 S (POLAND) NITROFURANTOIN CAPSULES USP (MACROCRYSTALS) 100MG, 100CT. DOXEPIN HYDROCHLORIDE CAPSULES USP, 10MG, 100CT. DOXEPIN HYDROCHLORIDE CAPSULES USP, 25MG, 100CT. ATORVASTATIN CALCIUM TABLETS 20 MG, 90 S CT FENOFIBRATE TABLETS USP 54 MG 90 S FENOFIBRATETABLETS USP 54 MG 500 S ATORVASTATIN CALCIUM TABLETS 10 MG, 1000 S CT LIDOCAINE HCL INJ., USP 2% (100 MG/5 ML) (20 MG/ML)- PRESERVATIV E FREE, 25X5ML PHENYLEPHRINE HYDROCHLORIDE INJ., USP, 50MG/5ML (10MG/ML), 10X5ML PHENYLEPH RINE HYDROCHLORIDE INJ., USP, 100MG/10ML (10MG/ML), 10ML ATORVASTATIN CALCIUM TABLETS 80 MG, 90 S CT ACETAZOLAMIDE TABLETS USP 125 MG 100 S (POLAND) NITROFURANTOIN CAPSULES USP (MACROCRYSTALS) 100MG, 100CT. DOXEPIN HYDROCHLORIDE CAPSULES USP, 10MG, 100CT. DOXEPIN HYDROCHLORIDE CAPSULES USP, 25MG, 100CT. |
2024-07-06 |
TLYIAHMORF240837 |
MANKIND PHARMA LTD |
18400.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 40 MG ATORVASTATIN CALCIUM TABLETS 20 MG, 90 S CT ATORVASTATIN CALCIUM TABLETS 40 MG CHLORTHALIDONE TABLETS USP 25MG 1000S NITROFURANTOIN CAPSULES USP RANOLAZINE ER TABLETS 500MG 60 S |
2024-07-06 |
TLYIAHMORF240833 |
MANKIND PHARMA LTD |
8664.0 kg |
291614
|
OMEGA-3-ACID ETHYL ESTERS CAPSULES 1GM |
2024-07-06 |
TLYIAHMORF240834 |
MANKIND PHARMA LTD |
9752.0 kg |
280512
|
ATORVASTATIN CALCIUM TABLETS 20 MG ATORVASTATIN CALCIUM TABLETS 40 MG NITROFURANTOIN CAPSULES USP |
2024-06-25 |
MFSRUS018716 |
MANKIND PHARMA LTD |
10198.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 40 MG, 90 S CT RANOLAZINE ER TABLETS 500MG 60 S |
2024-06-25 |
MFSRUS018715 |
MANKIND PHARMA LTD |
9516.0 kg |
848041
|
LIDOCAINE HYDROCHLORIDE INJECTION |
2024-06-15 |
TLYIAHMORF240740 |
MANKIND PHARMA LTD |
8328.0 kg |
291229
|
PHENYLEPHRINE HCL OPH. SOLN., USP, 10% PHENYLEPHRINE HCL OPH. SOLN., USP 2.5%, 2ML PRAZOSIN HYDROCHLORIDE CAPSULES, USP 1MG PRAZOSIN HYDROCHLORIDE CAPSULES, USP 5MG PRAZOSIN HYDROCHLORIDE CAPSULES, USP 2MG ALOSETRON TABLETS USP 0.5 MG ATORVASTATIN CALCIUM TABLETS 80 MG CHLORTHALIDONE TABLETS USP 50MG LANSOPRAZOLE DELAYED RELEASE CAPSULES 30MG |
2024-06-15 |
TLYIAHMORF240741 |
MANKIND PHARMA LTD |
9561.0 kg |
280512
|
ATORVASTATIN CALCIUM TABLETS 40 MG |
2024-06-15 |
YASVBOM0063465 |
MANKIND PHARMA LIMITED |
7823.0 kg |
280512
|
ATORVASTATIN CALCIUM TABLETS 40 MG, 90 S CT ATORVASTATIN CALCIUM TABLETS 40 MG, 1000 S CTPRAZOSIN HYDROCHLORIDE CAPSULES, USP 2MG, 1 00CT. |
2024-06-15 |
TLYIAHMORF240736 |
MANKIND PHARMA LTD |
5157.0 kg |
281420
|
FORMOTEROL FUMARATE INHALATION SOLUTION |
2024-06-15 |
TLYIAHMORF240737 |
MANKIND PHARMA LTD |
9737.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 20 MG, ATORVASTATIN CALCIUM TABLETS 80 MG, CHLORTHALIDONE TABLETS USP 25MG NITROFURANTOIN CAPSULES USP |
2024-06-08 |
TLYIAHMORF240697 |
MANKIND PHARMA LTD |
10168.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 10 MG ATORVASTATIN CALCIUM TABLETS 80 MG ATORVASTATIN CALCIUM TABLETS 40 MG AMITRIPTYLINE HCL TABLETS USP 25MG AMITRIPTYLINE HCL TABLETS USP 150MG ACETAZOLAMIDE TABLETS USP 125 MG ATORVASTATIN CALCIUM TABLETS 20 MG |
2024-06-05 |
TLYIAHMORF240688 |
MANKIND PHARMA LTD |
17745.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 10 MG ATORVASTATIN CALCIUM TABLETS 40 MG ATORVASTATIN CALCIUM TABLETS 80 MG ATORVASTATIN CALCIUM TABLETS 80 MG FENOFIBRATE TABLETS USP 160 MG |
2024-05-25 |
MFSRUS018607 |
MANKIND PHARMA LTD |
9768.0 kg |
300490
|
OMEGA-3-ACID ETHYL ESTERS CAPSULES 1GM, 120 CT CAPECITABINE TABLETS 500MG 120 S PACK NDC CODE: 70756-423-22, 70756-816-22 ANDA NO: 215458, 211724 FDA PRODUCT CODE: 62BCH14, 62ICA72DUNS NUMBER: 675584180, 650213072 FDA ESTABL ISHMENT NUMBER: 3006381009, 3009510975 HTS NO. 3004.90.9221, 3004.90.9215 |
2024-05-25 |
MFSRUS018606 |
MANKIND PHARMA LTD |
10455.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS 40 MG, 90 S CT ATORVASTATIN CALCIUM TABLETS 40 MG, 500 S CT ATORVASTATIN CALCIUM TABLETS 80 MG, 90 S CT NDC CODE: 70756-249-90, 70756-249-51, 70756-250-90 ANDA NO: 217081 FDA PRODUCT CODE: 61JCA08DUNS NUMBER: 916512493 FDA ESTABLISHMENT NUM BER: 3009083745 HTS NO. 3004.90.9221 |
2024-05-19 |
MFSRUS018580 |
MANKIND PHARMA LTD |
9844.0 kg |
291229
|
PHENYLEPHRINE HCL OPH.SOLN., USP, 10% , ATOR VASTATIN CALCIUM TABLETS 80 MG,500 S ATORVASTATIN CALCIUM TABLETS 80 MG, 90 S CT, A MITRIPTYLINE HCL TABLETS USP 75MG 100S, AMITRIPTYLINE HCL TABLETS USP 100MG 100S, CHLORTHALIDONETABLETS USP 25MG 100S, CHLORTHALIDONE TABLET S USP 25MG 1000S, LIDOCAINE HYDROCHLORIDE IN JECTION, USP 1% (100 MG/10 ML) (10 MG/ML)- WITH PRESERVATIVE PACK : 25X10ML PHENYLEPHRINE HYDROCHLORIDE INJ., USP, 50MG/5ML (10MG/ML) , 10X5ML |
2024-05-04 |
TLYIAHMORF240621 |
MANKIND PHARMA LTD |
9835.0 kg |
292250
|
PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP 2.5% 15 ML LIDOCAINE HYDROCHLORIDE INJECTION |
2024-05-04 |
TLYIAHMORF240623 |
MANKIND PHARMA LTD |
10071.0 kg |
280512
|
ATORVASTATIN CALCIUM TABLETS 20 MG ATORVASTATIN CALCIUM TABLETS 40 MG ATORVASTATIN CALCIUM TABLETS 80 MG PRAZOSIN HYDROCHLORIDE CAPSULES |
2024-05-04 |
TLYIAHMORF240619 |
MANKIND PHARMA LTD |
8791.0 kg |
280512
|
LANSOPRAZOLE DELAYED RELEASE CAPSULES 15MG LANSOPRAZOLE DELAYED RELEASE CAPSULES 30MG ATORVASTATIN CALCIUM TABLETS 80 MG ATORVASTATIN CALCIUM TABLETS 10 MG |
2024-05-03 |
TLYIAHMORF240658 |
MANKIND PHARMA LTD |
5912.0 kg |
281420
|
ARFORMOTEROL TARTRATE INHALATION SOLUTION STERILE UNIT-DOSE VIALS FORMOTEROL FUMARATE INHALATION SOLUTION TOBRAMYCIN INHALATION SOLUTION, USP 300 MG |
2024-05-03 |
TLYIAHMORF240662 |
MANKIND PHARMA LTD |
18802.0 kg |
280512
|
OMEGA-3-ACID ETHYL ESTERS CAPSULES 1GM OMEGA-3-ACID ETHYL ESTERS CAPSULES 1GM ATORVASTATIN CALCIUM TABLETS 20 MG ATORVASTATIN CALCIUM TABLETS 80 MG |
2024-05-03 |
TLYIAHMORF240660 |
MANKIND PHARMA LTD |
12281.0 kg |
291229
|
FENOFIBRATE TABLETS USP 160 MG 500 S FENOFIBRATE TABLETS USP 160 MG 90 S FENOFIBRATE TABLETS USP 54 MG 90 S ATORVASTATIN CALCIUM TABLETS 20 MG, 90 S CLOMIPRAMINE HCL CAPSULES USP 25MG 100 S CLOMIPRAMINE HCL CAPSULES USP 50MG 100 S CLOMIPRAMINE HCL CAPSULES USP 75MG 100 S |
2024-04-27 |
YASVBOM0062469 |
MANKIND PHARMA LTD |
18023.0 kg |
|
PHARMA PHARMA |
2024-04-08 |
MFSRUS018369 |
MANKIND PHARMA LTD |
5302.0 kg |
392330
|
ARFORMOTEROL TARTRATE INHALATION SOLUTION 15 MCG/2 ML (0.015 MG/2 ML) 60X2ML |
2024-04-08 |
MFSRUS018368 |
MANKIND PHARMA LTD |
9778.0 kg |
310510
|
ATORVASTATIN TABLETS 80 MG, 500 S CT, ATORVA STATIN TABLETS 10 MG, 90 S CT |
2024-04-05 |
TLYIAHMORF240563 |
MANKIND PHARMA LTD |
9733.0 kg |
310510
|
ATORVASTATIN CALCIUM TABLETS 10 MG, 90 S CT ATORVASTATIN CALCIUM TABLETS 20 MG, 1000 S CTCAPECITABINE TABLETS 500MG 120 S PACK |
2024-04-05 |
TLYIAHMORF240561 |
MANKIND PHARMA LTD |
10023.0 kg |
280512
|
NITROFURANTOIN CAPSULES USP ATORVASTATIN CALCIUM TABLETS 20 MG, 500 S CT ATORVASTATIN CALCIUM TABLETS 40 MG 90 S CT ATORVASTATIN CALCIUM TABLETS 20 MG, 90 S CT ATORVASTATIN CALCIUM TABLETS 20 MG, 1000 S CT |
2024-03-27 |
MFSRUS017594 |
MANKIND PHARMA LTD |
5992.0 kg |
300510
|
PHARMACEUTICAL GOODS |
2024-03-18 |
MFSRUS017576 |
MANKIND PHARMA LTD |
7107.0 kg |
392330
|
ARFORMOTEROL TARTRATE INHALATION SOLUTION 15 MCG/2 ML (0.015 MG/2 ML) 30X2ML STERILE UNIT-DOSE VIALS TOBRAMYCIN INHALATION SOLUTION, USP 300 MG/4 ML TOBRAMYCIN INHALATION SOLUTION,USP 300 MG/5 ML |
2024-03-18 |
MFSRUS017577 |
MANKIND PHARMA LTD |
8645.0 kg |
310510
|
AMITRIPTYLINE HCL TABLETS USP 25MG 100S ACETAZOLAMIDE TABLETS USP 125 MG 100 S (POLAND) NITROFURANTOIN CAPS USP (MONOHYDRATE/MACROCRYSTALS) 100 MG 100 CT FAMOTIDINE TABLETS, 20 MG-BOTTLE OF 1000 TABLETS FAMOTIDINE TABLETS, 40MG-BOTTLE OF 1000 TABLETS FAMOTIDINE TABLETS , 20 MG-BOTTLE OF 100 TABLETS FAMOTIDINE TABL ETS, 40 MG-BOTTLE OF 100 TABLETS |
2024-03-02 |
TLYIAHMORF240433 |
MANKIND PHARMA LTD |
8131.0 kg |
291229
|
LIDOCAINE HCL INJ NITROFURANTOIN CAPSULES USP BACLOFEN TABLETS USP |
2024-02-25 |
PUSJS2400316774 |
INVENTIA HEALTHCARE LIMITED |
4282.0 kg |
300490
|
2783 CORRUGATED CARTONS PACKED IN 20 PALLETS,AS PER PURCHASE ORDER NO. 4110004012 DTD 19.01.2024INVOICE NO. 2708000429 DTD 20.01.2024LANSOPRAZOLE DELAYED RELEASE CAPSULES 30MG 90 SNDC CODE : 70756-807-90ANDA NO : 205868FDA PRODUCT CODE : 62TCF02DUNS: 677604412FDA ESTABLISHMENT IDENTIFIER:3008232264HTS NO. 3004.90. 9259NET WT.: 1224.373 KGS.STORE AT 20C (77F);EXCURSIONS PERMITTED TO 15-30C(59-86F)H B/L NO. S2400316774SCAC CODE: PUSJGENSET REQUIRE |